Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
4.080
-0.360 (-8.11%)
At close: Oct 9, 2025, 4:00 PM EDT
3.820
-0.260 (-6.37%)
After-hours: Oct 9, 2025, 7:40 PM EDT

Arcadia Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
68372334
Upgrade
Market Cap Growth
43.01%132.51%-47.96%-71.05%-32.20%-28.18%
Upgrade
Enterprise Value
12-11-14-834
Upgrade
Last Close Price
4.085.923.1310.8441.60101.20
Upgrade
PS Ratio
1.031.600.781.343.404.24
Upgrade
PB Ratio
1.231.300.270.320.741.19
Upgrade
P/TBV Ratio
1.241.310.270.320.751.26
Upgrade
EV/Sales Ratio
0.210.34---4.24
Upgrade
Debt / Equity Ratio
0.000.030.080.100.110.33
Upgrade
Asset Turnover
0.430.300.180.140.150.20
Upgrade
Inventory Turnover
2.643.292.001.062.183.16
Upgrade
Quick Ratio
3.102.113.385.205.964.29
Upgrade
Current Ratio
4.123.614.176.037.025.02
Upgrade
Return on Equity (ROE)
-87.94%-45.62%-31.72%-14.62%-54.01%-32.68%
Upgrade
Return on Assets (ROA)
-32.83%-28.06%-15.04%-12.38%-33.30%-26.92%
Upgrade
Return on Capital (ROIC)
-49.50%-46.41%-19.96%-15.71%-41.98%-44.39%
Upgrade
Earnings Yield
-135.10%-87.10%-402.29%-230.24%-63.54%-13.68%
Upgrade
FCF Yield
-135.94%-119.34%-440.21%-210.37%-116.48%-95.66%
Upgrade
Buyback Yield / Dilution
-0.25%-10.22%-106.37%-12.66%-113.68%-56.51%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q